›Bharat Biotech s Karnataka facility will have capacity to make 4-5 crore doses of Covaxin a month by Aug-end: Minister
Bharat Biotech s Karnataka facility will have capacity to make 4-5 crore doses of Covaxin a month by Aug-end: Minister
SECTIONS
Bharat Biotech s Karnataka facility will have capacity to make 4-5 crore doses of Covaxin a month by Aug-end: MinisterPTI
Last Updated: May 17, 2021, 04:18 PM IST
Share
Synopsis
Karnataka has so far conducted 1.12 crore inoculations of coronavirus vaccines in the state comprising first and second doses whereas it has suspended the vaccination of people between the age group of 18 and 44, who are about 3.5 crore, due to shortage of vaccines.
Bengaluru
Karnataka
India
Hyderabad
Andhra-pradesh
Malur
Bharat
Jala-ella
Narendra-modi
Krishna-ella
Bharat-biotech
Bharat Biotech wants maximum price of covaxin to recover costs
Premium
Emergency Use Authorisation has been granted to two indigenously manufactured vaccines SII and Bharat Biotech, and a third vaccine (Sputnik) that while presently manufactured abroad will eventually be manufactured in India.
(REUTERS)
Dr Krishna Ella, CMD, Bharat Biotech, said that he would like to get the maximum price of covaxin to recover all costs, including Rs350 crore spent on clinical trials, in order to have money to work on vaccines for all kinds of infectious diseases
Share Via
Read Full Story
A day after central government allowed sale of covid-19 vaccines in open market, Dr Krishna Ella, Chairman and Managing Director, Bharat Biotech International Ltd, maker of covaxin, on Tuesday said that he would like to get the maximum price to recover all costs, including the ₹350 crore spent on clinical trials, in order to have money to work on vaccines for all kinds of infectious diseases.
India
Bharat
Krishna-ella
Bharat-biotech
Covid-19-vaccines
Dr-krishna-ella
Covaxin
Vaccination
இந்தியா
பாரத்
கிருஷ்ணா-எல்லா
Covaxin (Photo Credits: Bharat Biotech)
Hyderabad, February 24: Ukraine s Health Minister Maksym Stepanov on Wednesday visited Bharat Biotech s manufacturing facility here and held discussions on supplies of the company s Covid-19 vaccine Covaxin for his country.
A three-member led by the minister took a tour of the world-class Bio-Safety Level 3 manufacturing facility of Bharat Biotech, which has developed India s first indigenous vaccine for Covid-19.
The delegation, that included Deputy Health Minister Igor Ivashchenko, and Ukraine Embassy s Head of Trade and Economic Department Ivan Konovalov had discussions with Bharat Biotech s leadership to secure the supplies of Covaxin to Ukraine.
Bharat Biotech International Limited Chairman & Managing Director Dr Krishna Ella said it was privilege to host the Health Minister from Ukraine at our state-of-the-art facility and showcase our world-class capabilities in the manufacture and supply of vaccines and research and product de
Japan
Hyderabad
Andhra-pradesh
India
Ukraine
Japanese
Bharat
Igor-ivashchenko
Krishna-ella
Ukraine-health
Bharat-biotech-international
Deputy-health
vimarsana © 2020. All Rights Reserved.